Injectable Drugs Market – 2019-2025
Market Overview
Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.
Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-acting) effect from the same amount of the drug.
The injectable drugs market is expected to register a CAGR of nearly 11.1% during the forecast period, 2019-2024. The market is segmented by molecule type, drug-class, application, and geography
From the past one era of healthcare, biologics are increasingly becoming the driving forces of the pharmaceutical industry, and prefilled syringes have gained increased acceptance as delivery systems for injectable drugs in the treatment of chronic diseases.
Prefilled syringes are mainly sterilized via autoclaving or by ionizing radiation. Their ease of administration and the greater level of safety have increased the competition among the leading companies of injectable drugs.
With the need for more convenient drug-delivery methods, they are becoming the fastest-growing choices for unit dose medication (minimizing dosing error), in order to reduce the drug waste and increase the product life span.
The prefilled syringes have increased utilization across a wide range of therapeutic areas, such as blood stimulants, therapeutic proteins, and vaccines. With the rapid growth of the emerging markets, there is an increasing demand for patient-friendly parenteral delivery systems.
Get Sample Report PDF >>
The following manufacturers are covered:
AbbVie
F. Hoffmann-La Roche
GlaxoSmithKline
Sanofi
With the growing list of new compounds under new therapeutic classes, more complex technology is needed, along with higher investments.
The European market is well developed when compared to the US region, due to the presence of big pharmaceutical players, such as Becton-Dickinson, Gerresheimer, and Schott, among others.
The rising focus toward development considerations, such as pistons, barrels, needles, and needle shields, along with the compatibility of the drug product with the barrel contact surface, is crucial for the quality of drug products.
Thus, over the forecast period, a wide expansion of prefilled syringes is expected across the world, This is expected to drive the demand for injectable drugs.
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs
Browse Report »
Scope of the Report
As per the scope of the report, generic injectable refers to biologics that are used for the treatment of various drugs and has the same active ingredients to that of the branded versions of it, however, the inactive contents of the drugs can be varied.
The injectable drug market is gaining high importance in hospitals and clinics, with an increasing number of biologics, antibody-drug conjugates, and monoclonal antibodies in development, along with several injectable drugs under clinical trials status, globally.
Key Market Trends
By Molecule Type, Large Molecule has the Highest Share in the Market
The large molecule is dominating the market due to the steady rise of biologics, orphan drugs, and precision medicines across the biopharmaceutical industry. Furthermore, in 2017, the US FDA drug approval hit a record high, in which biologics and gene therapies played a significant part. With the increasing approval rate of biologics, the demand for injectable drugs is expected to rise significantly.
North America Region Holds the Largest Market Share of Injectable Drugs Market
North America dominates the Injectable Drugs market, owing to rapid developments in healthcare infrastructure, the presence of major players in the region, huge investments made in the research and development, and increased adoption of oncology-related drugs in hospitals to treat different cancers. Furthermore, the expansion of different companies to increase their production capacities is also drive the North American injectable drugs market.
Competitive Landscape
North America dominates the Injectable Drugs market, owing to rapid developments in healthcare infrastructure, the presence of major players in the region, huge investments made in the research and development, and increased adoption of oncology-related drugs in hospitals to treat different cancers. Furthermore, the expansion of different companies to increase their production capacities also drives the North American injectable drug market.
Customization of the Report
- Value chain analysis
- Consumer behavior analysis at country level
The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Injectable Drugs Speaker Market;
3.) the North American Injectable Drugs Speaker Market;
4.) the European Injectable Drugs Speaker Market;
5.) market entry and investment feasibility;
6.) the report conclusion.
Table of Content:
1 Study Coverage
2 Executive Summary
3 Breakdown Data by Manufacturers
4 Breakdown Data by Type
5 Breakdown Data by Application
…
11 Company Profiles
12 Future Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
14 Value Chain and Sales Channels Analysis
15 Research Findings and Conclusion
16 Appendix
The key insights of The report Research:
1.The report Research provides key statistics on the market status of the Injectable Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
2.The report Research provides a basic overview of the industry including its definition, applications and manufacturing technology.
3.The report Research presents the company profile, product specifications, capacity, production value, and 2019-2018 market shares for key vendors.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report Research estimates 2019-2025 market development trends of Injectable Drugs industry.
6.Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out
7.The report Research makes some important proposals for a new project of Injectable Drugs Industry before evaluating its feasibility.
Continued …
About Us:
“Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Spanning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories”.
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
Sales@Wiseguyreports.Com
Http://Www.Wiseguyreports.Com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
